1. P440 First results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). (27th May 2021) Authors: Geldof, J; Truyens, M; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P529 Evolution of COVID19 serology in a real-life population of IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). (21st January 2022) Authors: Geldof, J; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P593 Impact of immunomodulating treatment modalities, active smoking and (repeated) COVID19 vaccination on S-antibody seroconversion in IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID). (30th January 2023) Authors: Geldof, J; Truyens, M; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; de Vlam, K; Verschueren, P; Padalko, E; Lobaton, T; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗